Clinical Trial Update: A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector [Phase 2]

View source ↗

Summary

Phase 2B open-label, single-arm study evaluating the reliability of an autoinjector for delivering a treatment for systemic lupus erythematosus; the study is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2017-05-30